10.1055/b-0034-79131 Postoperative ConsiderationsMichael E. Seiff, Kelly Schmidt, and James Tait Goodrich Postoperative care begins with the patient′s emergence from anesthesia. The results of the initial neurologic examination obtained after awakening,…
10.1055/b-0034-79134 Posttherapy Neurologic SequelaeElizabeth M. Wells Greater recognition of adverse sequelae from multimodal therapy has accompanied the increase in pediatric brain tumor survival over the past three decades. This chapter…
10.1055/b-0034-79136 Second Tumors of the Central Nervous SystemJoseph P. Neglia Second neoplasms (SNs) were one of the first late effects recognized in survivors of childhood cancer.1 These events occur after…
10.1055/b-0034-79135 Cognitive ConsiderationsKarin S. Walsh Over the past 10 years there have been significant advances in the appreciation and understanding of the neurocognitive outcomes in pediatric brain tumor survivors. The…
10.1055/b-0034-79132 Cooperative Group Trials for Brain Tumors: Organization and Current DirectionsRoger J. Packer, Richard Sposto, David A. Walker, and Giorgio Perilongo The management of children with primary central nervous system…
10.1055/b-0034-79133 Postchemotherapy MorbidityGary Nicolin and Colin Kennedy For many decades the standard of care for brain tumors was surgery and radiotherapy. Chemotherapy for the treatment of leukemia and solid, non–central…
